Australia's largest stock trading and investment forum Australia's #1 stock forum

NXM nexus minerals limited

0.00%

7.1¢

NXM the next multi bagger, page-99

First 99 Last

Share
Profile

Follow
reeve123

241 Posts.

39

28/08/20

09:51

Post #: 46888354
Share

Originally posted by robbo24: ↑

Drilling results at Wallbrook with potential resource update and toll mining at SAR
Feasibility at Pinnacles with toll treatment at SAR (20-30k ounces per annum) beginning Q1 2020

Plenty going on here to justify a strong rerate.

My view all along was that the parties taking place in the placement were the cappers over the last 1-2 months, selling to fund payment of the second tranche. It's done now and the cash is raised, no one in their right mind would be selling this stock.

Expand

Good summary mate and it looks like youre right, not many are lining up to sell. Exciting times and will be even better when we start producing the yellow stuff. SAR must be looking at their cheque book.

NXM Price at posting: 8.7¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

First 99 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 7.1¢		Change 0.000(0.00%)		Mkt cap ! $42.86M

Open	High	Low	Value	Volume
7.0¢	7.5¢	7.0¢	$23.85K	328.0K

Buyers (Bids)

No.	Vol.	Price($)
3	29931	7.0¢

Sellers (Offers)

Price($)	Vol.	No.
7.1¢	109633	1

View Market Depth

No.	Vol.	Price($)
3	29931	0.070
1	40000	0.067
1	195000	0.066
3	330800	0.065
1	450000	0.062

Price($)	Vol.	No.
0.071	109633	1
0.074	17500	1
0.080	70000	2
0.084	20386	2
0.085	18418	2

Last trade - 15.55pm 27/06/2025 (20 minute delay)

NXM (ASX) Chart

NXM the next multi bagger, page-99

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Boss extends June win streak with boosted Alta Mesa extraction rates

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

NXM the next multi bagger, page-99

Top Stories

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Boss extends June win streak with boosted Alta Mesa extraction rates

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News